ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Patient-derived Xenograft (PDX) Models Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-22N5886
Home | Market Reports | Health| Nursing
Global Patient Derived Xenograft PDX Models Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Patient-derived Xenograft (PDX) Models Market Research Report 2025

Code: QYRE-Auto-22N5886
Report
March 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Crown Bioscience
The Jackson Laboratory
Champions Oncology
Charles River Laboratories
WuXi AppTec
Oncodesign
Horizon Discovery
Pharmatest Services
EPO Berlin-Buch
Xentech
Envigo
Urosphere
Medicilon
Shanghai Model Organisms Center
GemPharmatech
LIDE Biotech

Patient-derived Xenograft (PDX) Models Market Size

The global market for Patient-derived Xenograft (PDX) Models was valued at US$ 388 million in the year 2024 and is projected to reach a revised size of US$ 683 million by 2031, growing at a CAGR of 8.5% during the forecast period.

Patient-derived Xenograft (PDX) Models Market

Patient-derived Xenograft (PDX) Models Market

Global top 5 manufacturers of patient-derived xenograft (PDX) models occupied for a share nearly 45 percent, key players are Crown Bioscience, Champions Oncology, Wuxi Apptec, EPO Berlin-Buch, and Oncodesign, etc. Geographically speaking, Asia Pacific holds the most of global market share, about 35%. North America holds about 30% of share, while Europe followed by nearly 20%. In terms of type, mouse model accounted for nearly 75%, and rat model accounted for a share of 25%,The application of patient-derived xenograft (PDX) models includes preclinical drug development and biomarker analysis. Preclinical drug development shares over 75%, while biomarker analysis shares about 20%.
This report aims to provide a comprehensive presentation of the global market for Patient-derived Xenograft (PDX) Models, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Patient-derived Xenograft (PDX) Models.
The Patient-derived Xenograft (PDX) Models market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Patient-derived Xenograft (PDX) Models market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Patient-derived Xenograft (PDX) Models companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Patient-derived Xenograft (PDX) Models Market Report

Report Metric Details
Report Name Patient-derived Xenograft (PDX) Models Market
Accounted market size in year US$ 388 million
Forecasted market size in 2031 US$ 683 million
CAGR 8.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Mouse Model
  • Rat Model
Segment by Application
  • Preclinical Drug development
  • Biomarker Analysis
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Crown Bioscience, Champions Oncology, Wuxi Apptec, The Jackson Laboratory, EPO Berlin-Buch, Oncodesign, Xentech, Envigo, Charles River Laboratories, Pharmatest Services, Urosphere, MEDICILON, Horizon Discovery, Shanghai Model Organisms Center, GemPharmatech, LIDE Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Patient-derived Xenograft (PDX) Models company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Patient-derived Xenograft (PDX) Models Market growing?

Ans: The Patient-derived Xenograft (PDX) Models Market witnessing a CAGR of 8.5% during the forecast period 2025-2031.

What is the Patient-derived Xenograft (PDX) Models Market size in 2031?

Ans: The Patient-derived Xenograft (PDX) Models Market size in 2031 will be US$ 683 million.

What is the Patient-derived Xenograft (PDX) Models Market share by region?

Ans: Geographically speaking, Asia Pacific holds the most of global market share, about 35%.

What is the Patient-derived Xenograft (PDX) Models Market share by application?

Ans: Preclinical drug development shares over 75%, while biomarker analysis shares about 20%.

Who are the main players in the Patient-derived Xenograft (PDX) Models Market report?

Ans: The main players in the Patient-derived Xenograft (PDX) Models Market are Crown Bioscience, Champions Oncology, Wuxi Apptec, The Jackson Laboratory, EPO Berlin-Buch, Oncodesign, Xentech, Envigo, Charles River Laboratories, Pharmatest Services, Urosphere, MEDICILON, Horizon Discovery, Shanghai Model Organisms Center, GemPharmatech, LIDE Biotech

What are the Application segmentation covered in the Patient-derived Xenograft (PDX) Models Market report?

Ans: The Applications covered in the Patient-derived Xenograft (PDX) Models Market report are Preclinical Drug development, Biomarker Analysis

What are the Type segmentation covered in the Patient-derived Xenograft (PDX) Models Market report?

Ans: The Types covered in the Patient-derived Xenograft (PDX) Models Market report are Mouse Model, Rat Model

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Mouse Model
1.2.3 Rat Model
1.3 Market by Application
1.3.1 Global Patient-derived Xenograft (PDX) Models Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Preclinical Drug development
1.3.3 Biomarker Analysis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Patient-derived Xenograft (PDX) Models Market Perspective (2020-2031)
2.2 Global Patient-derived Xenograft (PDX) Models Growth Trends by Region
2.2.1 Global Patient-derived Xenograft (PDX) Models Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Patient-derived Xenograft (PDX) Models Historic Market Size by Region (2020-2025)
2.2.3 Patient-derived Xenograft (PDX) Models Forecasted Market Size by Region (2026-2031)
2.3 Patient-derived Xenograft (PDX) Models Market Dynamics
2.3.1 Patient-derived Xenograft (PDX) Models Industry Trends
2.3.2 Patient-derived Xenograft (PDX) Models Market Drivers
2.3.3 Patient-derived Xenograft (PDX) Models Market Challenges
2.3.4 Patient-derived Xenograft (PDX) Models Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patient-derived Xenograft (PDX) Models Players by Revenue
3.1.1 Global Top Patient-derived Xenograft (PDX) Models Players by Revenue (2020-2025)
3.1.2 Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Players (2020-2025)
3.2 Global Patient-derived Xenograft (PDX) Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Patient-derived Xenograft (PDX) Models Revenue
3.4 Global Patient-derived Xenograft (PDX) Models Market Concentration Ratio
3.4.1 Global Patient-derived Xenograft (PDX) Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patient-derived Xenograft (PDX) Models Revenue in 2024
3.5 Global Key Players of Patient-derived Xenograft (PDX) Models Head office and Area Served
3.6 Global Key Players of Patient-derived Xenograft (PDX) Models, Product and Application
3.7 Global Key Players of Patient-derived Xenograft (PDX) Models, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Patient-derived Xenograft (PDX) Models Breakdown Data by Type
4.1 Global Patient-derived Xenograft (PDX) Models Historic Market Size by Type (2020-2025)
4.2 Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Type (2026-2031)
5 Patient-derived Xenograft (PDX) Models Breakdown Data by Application
5.1 Global Patient-derived Xenograft (PDX) Models Historic Market Size by Application (2020-2025)
5.2 Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Patient-derived Xenograft (PDX) Models Market Size (2020-2031)
6.2 North America Patient-derived Xenograft (PDX) Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Patient-derived Xenograft (PDX) Models Market Size by Country (2020-2025)
6.4 North America Patient-derived Xenograft (PDX) Models Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Patient-derived Xenograft (PDX) Models Market Size (2020-2031)
7.2 Europe Patient-derived Xenograft (PDX) Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2020-2025)
7.4 Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size (2020-2031)
8.2 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region (2020-2025)
8.4 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Patient-derived Xenograft (PDX) Models Market Size (2020-2031)
9.2 Latin America Patient-derived Xenograft (PDX) Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2020-2025)
9.4 Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size (2020-2031)
10.2 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2020-2025)
10.4 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Details
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Introduction
11.1.4 Crown Bioscience Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.1.5 Crown Bioscience Recent Development
11.2 Champions Oncology
11.2.1 Champions Oncology Company Details
11.2.2 Champions Oncology Business Overview
11.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Introduction
11.2.4 Champions Oncology Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.2.5 Champions Oncology Recent Development
11.3 Wuxi Apptec
11.3.1 Wuxi Apptec Company Details
11.3.2 Wuxi Apptec Business Overview
11.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Introduction
11.3.4 Wuxi Apptec Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.3.5 Wuxi Apptec Recent Development
11.4 The Jackson Laboratory
11.4.1 The Jackson Laboratory Company Details
11.4.2 The Jackson Laboratory Business Overview
11.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Introduction
11.4.4 The Jackson Laboratory Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.4.5 The Jackson Laboratory Recent Development
11.5 EPO Berlin-Buch
11.5.1 EPO Berlin-Buch Company Details
11.5.2 EPO Berlin-Buch Business Overview
11.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Introduction
11.5.4 EPO Berlin-Buch Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.5.5 EPO Berlin-Buch Recent Development
11.6 Oncodesign
11.6.1 Oncodesign Company Details
11.6.2 Oncodesign Business Overview
11.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Introduction
11.6.4 Oncodesign Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.6.5 Oncodesign Recent Development
11.7 Xentech
11.7.1 Xentech Company Details
11.7.2 Xentech Business Overview
11.7.3 Xentech Patient-derived Xenograft (PDX) Models Introduction
11.7.4 Xentech Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.7.5 Xentech Recent Development
11.8 Envigo
11.8.1 Envigo Company Details
11.8.2 Envigo Business Overview
11.8.3 Envigo Patient-derived Xenograft (PDX) Models Introduction
11.8.4 Envigo Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.8.5 Envigo Recent Development
11.9 Charles River Laboratories
11.9.1 Charles River Laboratories Company Details
11.9.2 Charles River Laboratories Business Overview
11.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Introduction
11.9.4 Charles River Laboratories Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.9.5 Charles River Laboratories Recent Development
11.10 Pharmatest Services
11.10.1 Pharmatest Services Company Details
11.10.2 Pharmatest Services Business Overview
11.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Introduction
11.10.4 Pharmatest Services Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.10.5 Pharmatest Services Recent Development
11.11 Urosphere
11.11.1 Urosphere Company Details
11.11.2 Urosphere Business Overview
11.11.3 Urosphere Patient-derived Xenograft (PDX) Models Introduction
11.11.4 Urosphere Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.11.5 Urosphere Recent Development
11.12 MEDICILON
11.12.1 MEDICILON Company Details
11.12.2 MEDICILON Business Overview
11.12.3 MEDICILON Patient-derived Xenograft (PDX) Models Introduction
11.12.4 MEDICILON Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.12.5 MEDICILON Recent Development
11.13 Horizon Discovery
11.13.1 Horizon Discovery Company Details
11.13.2 Horizon Discovery Business Overview
11.13.3 Horizon Discovery Patient-derived Xenograft (PDX) Models Introduction
11.13.4 Horizon Discovery Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.13.5 Horizon Discovery Recent Development
11.14 Shanghai Model Organisms Center
11.14.1 Shanghai Model Organisms Center Company Details
11.14.2 Shanghai Model Organisms Center Business Overview
11.14.3 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Introduction
11.14.4 Shanghai Model Organisms Center Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.14.5 Shanghai Model Organisms Center Recent Development
11.15 GemPharmatech
11.15.1 GemPharmatech Company Details
11.15.2 GemPharmatech Business Overview
11.15.3 GemPharmatech Patient-derived Xenograft (PDX) Models Introduction
11.15.4 GemPharmatech Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.15.5 GemPharmatech Recent Development
11.16 LIDE Biotech
11.16.1 LIDE Biotech Company Details
11.16.2 LIDE Biotech Business Overview
11.16.3 LIDE Biotech Patient-derived Xenograft (PDX) Models Introduction
11.16.4 LIDE Biotech Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
11.16.5 LIDE Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Crown Bioscience
The Jackson Laboratory
Champions Oncology
Charles River Laboratories
WuXi AppTec
Oncodesign
Horizon Discovery
Pharmatest Services
EPO Berlin-Buch
Xentech
Envigo
Urosphere
Medicilon
Shanghai Model Organisms Center
GemPharmatech
LIDE Biotech
List of Tables
 Table 1. Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Mouse Model
 Table 3. Key Players of Rat Model
 Table 4. Global Patient-derived Xenograft (PDX) Models Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Patient-derived Xenograft (PDX) Models Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Patient-derived Xenograft (PDX) Models Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Patient-derived Xenograft (PDX) Models Market Share by Region (2020-2025)
 Table 8. Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Patient-derived Xenograft (PDX) Models Market Share by Region (2026-2031)
 Table 10. Patient-derived Xenograft (PDX) Models Market Trends
 Table 11. Patient-derived Xenograft (PDX) Models Market Drivers
 Table 12. Patient-derived Xenograft (PDX) Models Market Challenges
 Table 13. Patient-derived Xenograft (PDX) Models Market Restraints
 Table 14. Global Patient-derived Xenograft (PDX) Models Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Patient-derived Xenograft (PDX) Models Market Share by Players (2020-2025)
 Table 16. Global Top Patient-derived Xenograft (PDX) Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient-derived Xenograft (PDX) Models as of 2024)
 Table 17. Ranking of Global Top Patient-derived Xenograft (PDX) Models Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Patient-derived Xenograft (PDX) Models Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Patient-derived Xenograft (PDX) Models, Headquarters and Area Served
 Table 20. Global Key Players of Patient-derived Xenograft (PDX) Models, Product and Application
 Table 21. Global Key Players of Patient-derived Xenograft (PDX) Models, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Patient-derived Xenograft (PDX) Models Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2020-2025)
 Table 25. Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2026-2031)
 Table 27. Global Patient-derived Xenograft (PDX) Models Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2020-2025)
 Table 29. Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2026-2031)
 Table 31. North America Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Patient-derived Xenograft (PDX) Models Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Patient-derived Xenograft (PDX) Models Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Crown Bioscience Company Details
 Table 47. Crown Bioscience Business Overview
 Table 48. Crown Bioscience Patient-derived Xenograft (PDX) Models Product
 Table 49. Crown Bioscience Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 50. Crown Bioscience Recent Development
 Table 51. Champions Oncology Company Details
 Table 52. Champions Oncology Business Overview
 Table 53. Champions Oncology Patient-derived Xenograft (PDX) Models Product
 Table 54. Champions Oncology Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 55. Champions Oncology Recent Development
 Table 56. Wuxi Apptec Company Details
 Table 57. Wuxi Apptec Business Overview
 Table 58. Wuxi Apptec Patient-derived Xenograft (PDX) Models Product
 Table 59. Wuxi Apptec Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 60. Wuxi Apptec Recent Development
 Table 61. The Jackson Laboratory Company Details
 Table 62. The Jackson Laboratory Business Overview
 Table 63. The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product
 Table 64. The Jackson Laboratory Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 65. The Jackson Laboratory Recent Development
 Table 66. EPO Berlin-Buch Company Details
 Table 67. EPO Berlin-Buch Business Overview
 Table 68. EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product
 Table 69. EPO Berlin-Buch Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 70. EPO Berlin-Buch Recent Development
 Table 71. Oncodesign Company Details
 Table 72. Oncodesign Business Overview
 Table 73. Oncodesign Patient-derived Xenograft (PDX) Models Product
 Table 74. Oncodesign Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 75. Oncodesign Recent Development
 Table 76. Xentech Company Details
 Table 77. Xentech Business Overview
 Table 78. Xentech Patient-derived Xenograft (PDX) Models Product
 Table 79. Xentech Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 80. Xentech Recent Development
 Table 81. Envigo Company Details
 Table 82. Envigo Business Overview
 Table 83. Envigo Patient-derived Xenograft (PDX) Models Product
 Table 84. Envigo Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 85. Envigo Recent Development
 Table 86. Charles River Laboratories Company Details
 Table 87. Charles River Laboratories Business Overview
 Table 88. Charles River Laboratories Patient-derived Xenograft (PDX) Models Product
 Table 89. Charles River Laboratories Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 90. Charles River Laboratories Recent Development
 Table 91. Pharmatest Services Company Details
 Table 92. Pharmatest Services Business Overview
 Table 93. Pharmatest Services Patient-derived Xenograft (PDX) Models Product
 Table 94. Pharmatest Services Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 95. Pharmatest Services Recent Development
 Table 96. Urosphere Company Details
 Table 97. Urosphere Business Overview
 Table 98. Urosphere Patient-derived Xenograft (PDX) Models Product
 Table 99. Urosphere Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 100. Urosphere Recent Development
 Table 101. MEDICILON Company Details
 Table 102. MEDICILON Business Overview
 Table 103. MEDICILON Patient-derived Xenograft (PDX) Models Product
 Table 104. MEDICILON Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 105. MEDICILON Recent Development
 Table 106. Horizon Discovery Company Details
 Table 107. Horizon Discovery Business Overview
 Table 108. Horizon Discovery Patient-derived Xenograft (PDX) Models Product
 Table 109. Horizon Discovery Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 110. Horizon Discovery Recent Development
 Table 111. Shanghai Model Organisms Center Company Details
 Table 112. Shanghai Model Organisms Center Business Overview
 Table 113. Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product
 Table 114. Shanghai Model Organisms Center Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 115. Shanghai Model Organisms Center Recent Development
 Table 116. GemPharmatech Company Details
 Table 117. GemPharmatech Business Overview
 Table 118. GemPharmatech Patient-derived Xenograft (PDX) Models Product
 Table 119. GemPharmatech Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 120. GemPharmatech Recent Development
 Table 121. LIDE Biotech Company Details
 Table 122. LIDE Biotech Business Overview
 Table 123. LIDE Biotech Patient-derived Xenograft (PDX) Models Product
 Table 124. LIDE Biotech Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
 Table 125. LIDE Biotech Recent Development
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources
 Table 129. Authors List of This Report


List of Figures
 Figure 1. Patient-derived Xenograft (PDX) Models Picture
 Figure 2. Global Patient-derived Xenograft (PDX) Models Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Patient-derived Xenograft (PDX) Models Market Share by Type: 2024 VS 2031
 Figure 4. Mouse Model Features
 Figure 5. Rat Model Features
 Figure 6. Global Patient-derived Xenograft (PDX) Models Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Patient-derived Xenograft (PDX) Models Market Share by Application: 2024 VS 2031
 Figure 8. Preclinical Drug development Case Studies
 Figure 9. Biomarker Analysis Case Studies
 Figure 10. Patient-derived Xenograft (PDX) Models Report Years Considered
 Figure 11. Global Patient-derived Xenograft (PDX) Models Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Patient-derived Xenograft (PDX) Models Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Patient-derived Xenograft (PDX) Models Market Share by Region: 2024 VS 2031
 Figure 14. Global Patient-derived Xenograft (PDX) Models Market Share by Players in 2024
 Figure 15. Global Top Patient-derived Xenograft (PDX) Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient-derived Xenograft (PDX) Models as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Patient-derived Xenograft (PDX) Models Revenue in 2024
 Figure 17. North America Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Patient-derived Xenograft (PDX) Models Market Share by Country (2020-2031)
 Figure 19. United States Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Patient-derived Xenograft (PDX) Models Market Share by Country (2020-2031)
 Figure 23. Germany Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Share by Region (2020-2031)
 Figure 31. China Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Patient-derived Xenograft (PDX) Models Market Share by Country (2020-2031)
 Figure 39. Mexico Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Share by Country (2020-2031)
 Figure 43. Turkey Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Crown Bioscience Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 47. Champions Oncology Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 48. Wuxi Apptec Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 49. The Jackson Laboratory Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 50. EPO Berlin-Buch Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 51. Oncodesign Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 52. Xentech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 53. Envigo Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 54. Charles River Laboratories Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 55. Pharmatest Services Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 56. Urosphere Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 57. MEDICILON Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 58. Horizon Discovery Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 59. Shanghai Model Organisms Center Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 60. GemPharmatech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 61. LIDE Biotech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Medical Simulation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-7S2681
Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Patient-derived Xenograft (PDX) Models Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22N5886
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Defensin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24X10377
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Acupuncture Needles Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-27A351
Wed Mar 19 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions